Company / Revenue
Pasithea Therapeutics Corp. Revenue History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$15.1K
FY2022
5-year range
$15.1K / $15.1K
FY2021-FY2022
Trend
+0.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$15,062 in FY2022.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, revenue increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $15.1K | +0.0% |
| FY2021 | $15.1K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026